Search

everythinglearnresearchcommunity

for

Search:↓

Latanoprost can make eyelashes longer, thicker, and darker.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

Early hair loss may indicate prostate issues.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Testosterone is key for male sexual function, and treating hormone imbalances can improve sexual issues.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Melatonin receptors in hair follicles help regulate hair growth and could treat hair loss.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Dermal adipose tissue in mice can change and revert to help with skin health.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.